Table 2.
Odds ratio | p-value | 95% Confidence interval | ||
---|---|---|---|---|
Clinical parameters | ||||
Age | 1.15 | <0.001a | 1.08 | 1.22 |
Male gender | 1.55 | 0.42 | 0.53 | 4.56 |
Hypertension | 2.23 | 0.03a | 1.08 | 4.63 |
Diabetes | 0.90 | 0.88 | 0.23 | 3.51 |
With history of smoking | 1.32 | 0.45 | 0.64 | 2.71 |
Total cholesterol/HDL ratio | 0.98 | 0.55 | 0.91 | 1.05 |
FRS risk category | ||||
Low risk (<10%) | Ref | Ref | Ref | Ref |
Intermediate risk (10–20%) | 3.06 | 0.02a | 1.16 | 8.09 |
High risk (>20%) | 5.25 | 0.003a | 1.75 | 15.80 |
Current CD4% | 1.00 | 0.78 | 0.97 | 1.03 |
Soluble biomarkersb | ||||
sE selectin | 1.08 | 0.90 | 0.29 | 4.12 |
sVCAM-1 | 8.97 | 0.13 | 0.52 | 153.78 |
sICAM-1 | 2.40 | 0.33 | 0.42 | 13.67 |
MMP-9 | 1.10 | 0.87 | 0.33 | 3.74 |
MPO | 1.09 | 0.88 | 0.37 | 3.21 |
tPAI-1 | 1.73 | 0.54 | 0.30 | 10.14 |
CRP | 1.28 | 0.30 | 0.80 | 2.04 |
SAA | 1.14 | 0.54 | 0.75 | 1.75 |
SAP | 1.01 | 0.98 | 0.44 | 2.34 |
IL-1β | 0.95 | 0.96 | 0.12 | 7.48 |
IL-6 | 1.84 | 0.15 | 0.81 | 4.22 |
IL-8 | 1.44 | 0.68 | 0.25 | 8.10 |
IL-10 | 1.12 | 0.65 | 0.68 | 1.83 |
TNF-α | 3.70 | 0.01a | 1.30 | 10.48 |
MCP-1 | 12.2 | 0.03a | 1.27 | 117.77 |
VEGF | 1.87 | 0.12 | 0.84 | 4.16 |
IFN-γ | 0.81 | 0.61 | 0.36 | 1.84 |
NT-proBNP | 1.34 | 0.38 | 0.70 | 2.58 |
Statistically significant.
Odds ratios were calculated based on log-transformed values of soluble biomarkers.